NCT07582848

BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-07-22Est. Completion: 2029-06

Enrollment target: 266 participants

Locations

Phoenix Children's Hospital, Phoenix, Arizona, United States
Children's Hospital of Los Angeles, Los Angeles, California, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Lurie Children's Hospital, Chicago, Illinois, United States
Golisano Children's at UK, Lexington, Kentucky, United States
Boston Children's Hospital, Boston, Massachusetts, United States
University of Michigan Health System, Ann Arbor, Ann Arbor, Michigan, United States
Children's Mercy Hospital, Kansas City, Missouri, United States
Washington University School of Medicine, St Louis, Missouri, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Children's Hospital of New York, New York, New York, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Medical University of South Carolina, Charleston, South Carolina, United States

Supraventricular Tachycardia (SVT)Congenital Heart Disease (CHD)

The goal of this observational study is to collect real world performance and to confirm the effectiveness and safety of…

Multiple LocationsEst. completion Jan 31, 2029

CHD - Congenital Heart Disease

Group (A): This group will receive fentanyl infusion at a dose of (0.5μg/kg/h) all through the whole operation plus ultr…

Cairo, EgyptEst. completion Dec 1, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.